%20Comprehensive%20Guide%20to%20Neurological%20Pharmacotherapy.webp "Drugs in Neurology, 2nd Edition (2025) Comprehensive Guide to Neurological Pharmacotherapy")
What is Drugs in Neurology, 2nd Edition (2025)?
Drugs in Neurology, 2nd Edition (2025) is a comprehensive clinical reference that explores the pharmacological management of adult neurological disorders. Designed for neurologists, trainees, clinical pharmacologists, and healthcare professionals, it combines disease-focused treatment guidance with detailed information on neurological medications and evidence-based therapeutics.
Introduction
Neurological therapeutics have evolved rapidly in recent years, with new disease-modifying treatments transforming the management of many previously untreatable neurological conditions.
Drugs in Neurology, Second Edition, reflects these advances by providing an updated, evidence-based guide to the medications used across a broad spectrum of adult neurological diseases.
Published by Oxford University Press in 2025, this reference is designed to bridge the gap between neurological disease management and clinical pharmacology.
Rather than functioning solely as a drug handbook, the book integrates disease-focused treatment strategies, pharmacological principles, and evidence-based recommendations into a single resource.
The text is particularly valuable for neurology trainees, residents, clinical pharmacologists, practicing neurologists, and healthcare professionals involved in the care of adults with neurological disorders.
According to the editors, emphasis is placed on both the pharmacological foundations of therapy and the evidence supporting treatment decisions, while also recognizing the importance of expert clinical experience.
Book Overview
|
Detail |
Information |
|
Full
Title |
Drugs in Neurology |
|
Edition |
Second Edition |
|
Editors |
Sathiji K. Nageshwaran, David
Ledingham, Heather C. Wilson |
|
Publisher |
Oxford University Press |
|
Publication
Year |
2025 |
|
ISBN |
978-0-19-886969-6 |
|
Medical
Specialty |
Neurology / Clinical Pharmacology |
|
Intended
Audience |
Neurologists, residents, trainees,
clinical pharmacologists, and healthcare professionals caring for adults with
neurological disorders |
WHAT THIS BOOK COVERS
One of the distinguishing features of Drugs in Neurology, 2nd Edition, is its dual structure. The book is divided into two major sections: neurological conditions and neurological drugs.
This allows readers to approach clinical problems from either a disease-management perspective or a medication-focused perspective.
The neurological conditions section covers a broad range of disorders encountered in clinical practice, including:
- Headache disorders
- Vertigo and vestibular syndromes
- Epilepsy
- Cerebrovascular disease and stroke
- Neuropathic pain
- Multiple sclerosis and related disorders
- Inflammatory CNS disorders
- Peripheral nerve disorders
- Motor neuron disease
- Muscle diseases
- Neuromuscular junction disorders
- Parkinson's disease and Parkinsonism
- Hyperkinetic movement disorders
- Dementia
- Spasticity
- Neuro-oncology
- Sleep disorders
- Neurological infections
- Metabolic neurological disorders
- Uro-neurology
- Drug-induced neurological disease
- Neurogenetics
The editors note that the second edition introduces a new chapter dedicated to neurogenetics, reflecting the growing importance of precision medicine and genetically targeted therapies in neurology.
In addition to disease-specific chapters, the book includes extensive coverage of neurological drug classes and an A–Z index of neurological medications.
Key Features
- Comprehensive coverage of adult neurological diseases
- Focus on pharmacological mechanisms and therapeutic decision-making
- Evidence-based treatment recommendations
- Contributions from internationally recognized neurology experts
- Integration of UK and US clinical perspectives
- Dedicated chapter on neurogenetics
- Disease-focused and drug-focused organizational structure
- Extensive drug reference section
- Practical guidance for everyday clinical management
- Suitable for both study and clinical practice
Who Should Read This Book
Neurology Residents and Trainees
The editors specifically state that the book is intended for trainees in neurology and clinical pharmacology. It provides a practical framework for understanding medication selection, treatment algorithms, and evidence-based prescribing.
Practicing Neurologists
Clinicians managing patients with epilepsy, stroke, movement disorders, neuroimmunological diseases, headache disorders, and other neurological conditions will find updated therapeutic guidance throughout the text.
Clinical Pharmacologists
The emphasis on pharmacological mechanisms and drug evidence makes the book particularly relevant for professionals interested in therapeutic optimization.
Medical Educators
The structured disease-based approach supports teaching activities and clinical training programs.
Healthcare Professionals
Advanced practice providers, specialist nurses, and healthcare professionals working in neurology may benefit from the book's therapeutic focus.
Why This Book Is Useful
Strong Clinical Relevance
The text addresses real-world management of common and complex neurological disorders, emphasizing practical therapeutic decision-making.
Evidence-Based Approach
According to the editors, treatment recommendations are grounded in pharmacological science and the available evidence base while incorporating expert clinical experience.
Contemporary Neurology
The second edition reflects ongoing advances in neurological therapeutics, including disease-modifying treatments and modern neurogenetic approaches.
Efficient Learning Resource
By combining disease overviews, treatment recommendations, and drug information within a single reference, the book helps streamline clinical learning.
Board and Examination Preparation
The concise yet comprehensive format may support review for neurology trainees and residents preparing for examinations.
Table of Contents Overview
Section 1: Neurological Conditions
- Headache
- Vertigo
- Epilepsy
- Cerebrovascular Disease
- Neuropathic Pain
- Multiple Sclerosis and Related Disorders
- Other Inflammatory Disorders of the CNS
- Disorders of Peripheral Nerves
- Motor Neuron Disease
- Disorders of Muscle
- Disorders of the Neuromuscular Junction
- Parkinson's Disease and Parkinsonism
- Hyperkinetic Movement Disorders
- Dementia
- Spasticity
- Neuro-Oncology
- Sleep Disorders
- Neurological Infections
- Metabolic Disorders
- Uro-Neurology
- Drugs Causing Neurological Disease
- Neurogenetics
Section 2: Drugs
- Drug Classes
- A–Z Index of Neurological Drugs
Strengths of the Book
Comprehensive Scope
The book spans both neurological diseases and therapeutic agents, providing readers with a broad yet clinically focused resource.
International Expert Contributions
Contributors include neurologists, neuroscientists, and academic physicians from major institutions in the United Kingdom, the United States, and Canada.
Updated Content
The second edition has been completely updated and incorporates developments in neurological therapeutics, including a dedicated neurogenetics chapter.
Practical Clinical Orientation
The foreword highlights the book's concise writing style and balanced guidance on treatment across major categories of neurological disease.
Educational Value
The text is described as valuable for clinical practice as well as for students, registrars, and residents reviewing neurology knowledge.
Limitations
- The primary focus is adult neurological disease management; pediatric neurology coverage is not described.
- The book is centered on pharmacological treatment and may not provide the same depth of detail regarding diagnostic neurology as comprehensive neurology textbooks.
- The source does not indicate extensive coverage of procedural or surgical neurology.
Comparison With Similar Books
Compared with broad neurology textbooks, Drugs in Neurology appears more focused on therapeutic decision-making and pharmacological management.
Unlike traditional disease-oriented neurology references, this book combines the following:
- Disease management strategies
- Pharmacological principles
- Drug-specific information
- Evidence-based treatment recommendations
The source material emphasizes its distinctive combination of neurological therapeutics and clinical pharmacology.
Drugs in Neurology, 2nd Edition
FAQs
It is a comprehensive neurology pharmacotherapy reference that covers the treatment of adult neurological disorders and provides detailed information on neurological medications.
The book is edited by Sathiji K. Nageshwaran, David Ledingham, and Heather C. Wilson.
The second edition is fully updated and includes a new chapter on neurogenetics.
Yes. The editors state that emphasis is placed on pharmacological foundations and the evidence supporting therapeutic use.
The book covers headache, epilepsy, stroke, multiple sclerosis, dementia, Parkinson's disease, sleep disorders, neuro-oncology, neurogenetics, and many other neurological conditions.
Yes. The editors specifically indicate that the book is intended to be valuable for neurology trainees and clinical pharmacology trainees.
Yes. A dedicated section covers drug classes and includes an A–Z index of neurological medications.
The book is published by Oxford University Press.
Conclusion
Drugs in Neurology, 2nd Edition (2025), is a valuable resource for clinicians and trainees seeking an up-to-date guide to neurological pharmacotherapy. By combining disease-focused management strategies with detailed medication information, the book offers a practical and evidence-based approach to treating adult neurological disorders.
Its comprehensive scope, international authorship, and inclusion of emerging areas such as neurogenetics make it a useful addition to the libraries of neurologists, residents, clinical pharmacologists, and healthcare professionals involved in neurological care.
Disclaimer
MedBook 4 Free does not own copyrights to this video/book/software. We’re sharing this with our audience ONLY for educational purposes, and we highly encourage our visitors to purchase original licensed software/books.
If someone with copyrights wants us to remove this software/book, please contact us immediately. You can send an email to [email protected] for all DMCA / removal requests.